Leptin and cardiovascular disease: response to therapeutic interventions

Circulation. 2008 Jun 24;117(25):3238-49. doi: 10.1161/CIRCULATIONAHA.107.741645.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Animals
  • Antihypertensive Agents / therapeutic use
  • Calcium Channel Blockers / therapeutic use
  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / genetics
  • Cardiovascular Diseases* / metabolism
  • Diabetes Mellitus / metabolism
  • Drug Therapy, Combination
  • Humans
  • Hypertension / drug therapy
  • Hypertension / genetics
  • Hypertension / metabolism
  • Insulin Resistance*
  • Leptin / genetics
  • Leptin / metabolism*
  • Obesity / genetics
  • Obesity / metabolism*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Leptin